Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, June 16, 2024 | Back issues
Courthouse News Service Courthouse News Service

$600 Million Settlement for Pushing Botox

JEFFERSON CITY, Mo. (CN) - Allergan will pay $600 million to settle claims that it pushed Botox for off-label uses. Allergan will pay states and the federal government $225 million to compensate Medicare and Medicaid, plus $350 million in criminal fines and $25 million in forfeiture, Attorney General Chris Koster said.

The company pleaded guilty to a misdemeanor violation of the Food, Drug and Cosmetic Act.

The settlement resolves claims that Allergan promoted Botox for unapproved uses such as headache, pain, overactive bladder and spasticity.

Allergan ran a nationwide campaign to push the drug for off-label uses. It included reimbursements to physicians and other support.

Doctors may prescribe drugs for off-label uses, but drug companies cannot push their drugs for that. Missouri will get $1.6 million from the settlement, Koster said.

Follow @@joeharris_stl
Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.